Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment

Eitemau Tebyg

• BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility
  gan: Zheng, Xiaomin, et al.
  Cyhoeddwyd: (2006)
• The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
  gan: Anahita Rafiei, et al.
  Cyhoeddwyd: (2015-04-01)
• The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia
  gan: Rafiei, Anahita, et al.
  Cyhoeddwyd: (2015)
• De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome
  gan: Min, Xiao, et al.
  Cyhoeddwyd: (2011)
• STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
  gan: Oancea, Claudia, et al.
  Cyhoeddwyd: (2014)